Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If we get a report of 20 billion plus in precious metals and your a shareholder that feels the stock price won't appreciate past 40 cents something tells me you should either sell the stock as the risk reward is too small or put your money to work elsewhere.
I do believe that some will sell on news but I also believe this will be above a dollar per share simply based on this huge huge news if and when it comes IMHO.
I also believe that's rather than doing all the testing it will take to sell this for full value will not be done and that it will rather be sold at a slight discount so the people that discovered this will be able to cash out and move from Marlboro to Boca and eat a lot of steak and lobster at NY prime.
Ok I'm done and now hungry.
I agree 100 percent!
Five minutes left to buy in if the news come out pre open tomorrow.
Just ignore them one side is going to be correct and hope it's ours!!!
Improving the website prior to announcing this news is a very good strategy and there will be a host of new investors looking at it very soon IMHO.
New out!! Earnings,
Milestone Scientific Announces Financial Results for the Second Quarter of 2014
Revenue Increases 10.0% to $2.5 Million; Domestic Handpiece Sales Increase 22.0%; International Handpiece Sales Increase 20.1%; Domestic Sales Increase 9.3%; International Sales Increase 10.7%; Shareholders' Equity Increases to $15.3 Million
LIVINGSTON, NJ--(Marketwired - August 14, 2014) - Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results and provided a business update for the three and six months ended June 30, 2014.
Leonard Osser, Chief Executive Officer of Milestone Scientific stated, "We are making progress advancing our epidural and intra-articular instruments through the regulatory process. We have developed a broad platform of computer-controlled injection technologies serving a wide array of medical applications and we look forward to announcing additional medical instruments later this year."
"We are also adding strategic resources that we believe will help us advance both our dental and medical instruments. We recently announced the appointment of Gian Domenico Trombetta as Chief Executive Officer of the dental division. He has an impressive track record leading high growth companies across a broad range of industries. We also announced the appointment as Marketing Consultant of Steven Robins, who has overseen the marketing and operations for billion dollar divisions of Fortune 500 healthcare and consumer product companies. Both executives bring valuable industry contracts and expertise."
Mr. Osser continued, "Total revenue for the second quarter of 2014 increased 10.0% to $2.5 million. We achieved a 22.0% increase in domestic handpiece sales and a 20.1% increase in international handpiece sales. This growth in domestic handpieces is due in part to the greater transparency we have with our customers, through our exclusive distributor Aseptico. We are able to establish direct relationships with the dentists and train them properly so they can utilize a greater number of handpieces per year."
"During the second quarter, we announced a $10 million financing which enables us to accelerate the development of additional medical instruments based on our patented CompuFlo and Dynamic Pressure Sensing technologies. Future medical applications of our technologies which will benefit from this investment could include colorectal surgery, podiatry, dermatology, orthopedics, nasal and sinus surgery, and cosmetic surgery, among others. The financing also allows us to more aggressively market and sell our dental instruments and handpieces in the United States and worldwide. As a result of this financing, we now have over $15 million of shareholders' equity. Given the strength of our balance sheet and continued positive cash flow from operations, we believe we are well positioned in the months and years ahead."
Revenue for the three months ended June 30, 2014 was $2.5 million versus $2.3 million for the second quarter of 2013. Domestic instrument sales decreased by $33,376 or 8.7% in the second quarter of 2014 versus the same period in 2013 due to lower distributor purchase prices for the STA instruments for a limited time period. The strategy is to facilitate the deployment of the STA instruments at a faster pace, thus generating recurring handpiece revenue. Domestic handpiece sales increased by $146,527, or 22.0% in 2014 over 2013. On the international front, instrument sales decreased by $34,677 or 9.4% in the second quarter of 2014 versus the same period in 2013. International handpiece sales increased by $162,758 or 20.1% in the second quarter of 2014 versus 2013. Gross profit for the second quarter of 2014 was $1.6 million or 63.6% of revenue versus $1.5 million or 67.3% of revenue for the second quarter of 2013. The decrease in gross margin reflected the lower pricing strategy on the instruments to drive handpiece sales. Operating income for the second quarter of 2014 was $47,507 versus an income of $151,113 for the second quarter of 2013. Net loss for the second quarter of 2014 was ($169,457), or $(0.01) per share, versus an income of $74,009 or $0.00 per share for the comparable period in 2013. Net loss for the second quarter of 2014 includes a Loss on Earnings from Medical Joint Venture of ($213,193) compared to ($47,093) for the three months ended June 30, 2013. Also, the June 30, 2013 net income included the positive impact of the reversal of the bad debt reserve for uncollectable accounts in 2013 that did not occur in 2014.
Revenue for the six months ended June 30, 2014 was $5.1 million versus $4.8 million for the six months ended June 30, 2013. In the domestic market, total revenue was approximately equal in both periods. On the international front, total revenue increased by $345,924 to $2.7 million versus $2.4 million for the same period in 2013. Gross profit for the six months ended June 30, 2014 was $3.3 million or 65.0% of revenue versus $3.2 million or 67.4% of revenue for the six months ended June 30, 2013. Operating income for the six months ended June 30, 2014 was $376,753 versus an income of $318,874 for the six months ended June 30, 2013. Net income for the six months ended June 30, 2014 was $25,377, or $0.00 per share, versus an income of $224,754, or $0.01 per share, for the comparable period in 2013. Net income for the six months ended June 30, 2014 includes a Loss on Earnings from Medical Joint Venture of ($343,716) compared to ($47,093) for the same period last year.
Milestone's executive management team will host a teleconference on Thursday, August 14, 2014 at 8:30 A.M. Eastern Time to discuss the company's financial results.
The conference call will be available via telephone by dialing toll free 1-888-359-3627 and entering the pass code 8220117 or on the company's website at www.milestonescientific.com. For those unable to participate at that time, a replay of the call will be archived on the company's website or can be accessed by dialing 1-888-203-1112 and entering the pass code 8220117. The replay will be available for 90 days.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2013. The forward looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
(tables follow)
MILESTONE SCIENTIFIC INC.
Good morning team Uspr another day closer to the results!
Hoping for another green day!
That's the BIG 3 in mind, if one leaves like Lebron did Miami I too will reevaluate.
I won't move to Cleveland though.
Another day closer and another day of a higher stock price.
Hope we trickle up everyday now and then BOOM!
I can wait out the month easy at this pace.
Wow the people that invested the 40mm in the secondary within 2 months must be highly uneducated!
I must have made a huge mistake.
Ravvc
Good luck to all my fellow longs this week.
Hoping we get the results that we need.
Sorry out for may dads bday and sent before spell check!
Its funny the way you turned after 5 years acuataly comical. I could care less you sold but the negtibeikty towards a stock that you have already stated you souls bel you money in over 4 years.....to me you sound like a complete ahole!
I agree!! Results imminently close.
Hilarious
Hey everyone we now know CIUN source now the new BFF's.
Not that it doesn't make sense and explain why the stock price isn't 10 bucks today.
I just find this new ltg and CUIN
I should have said IMHO.
Not a chance unless they chose you for the trials.
I'm not worried, lack of short interest is a positive.
July 15th???? Your concerned with the selling for the last 4 weeks so your info is inaccurate.
But you know that.
I agree that pattern existed prior to the financing they raised to get them thru to commercialization.
That's great, very happy for you. I'm surprised as smart as you are you didn't sell the 2.57 top.
That a hysterical question considering how insulted you got when I merely asked what percentage of your holding you sold off and you jumped off the deep end with some other unnamed mb poster.
You wouldn't answer but I will. I have paper profits and as you know they aren't realized until you sell.
CUIN I've been in the market for decades you know smarter than anyone else because you guessed right so far.
Must be the same sources that put him in the stock 4 years to early.
Russo your short info is wrong you have actually gotten off about a million shares as the OTC markets take a looks here's the proof in writing:
http://otcshortreport.com/index.php?index=uspr&action=view#.U-LJ52d0zIV
Omg it traded it's daily average volume!!!!
The sky is falling!!! Beware.
The selling was addressed by many on the board including myself.
So give it a rest and move on from this discussion its a bunch of poop.
Nah na nah na pooo pooooo that is ruu
If they were so smart and they are not short the stock why would they have bought in the first place.
Next.
The shorts are getting very afraid as they should be, they will be forced to cover soon at much higher prices when the smart money comes into buy.
That's why you messages are being deleted.
They are running scared!
But news is around the corner and we are hoping it's great!
Russo your posts alone can spook people into selling alone period.
That is most likely why there is selling, your posts are working, congrats.
But what do I know oh:
Great news coming within the next two weeks.
Nah na nah na pooooo poo
Had anyone recently spoke to Steve Chizzik and asked if the results will be out this week?
He is their IR person correct?
News will be out this week or the next everything else is as you all know by now:
Nah na nah na poopoooo
IMHO
It's back to your entry point price.
Good morning team USPR.
Another day closer to reserves and the stock is holding well.
Good luck to all the longs if you hear or see anything please post it for us to see as I will do the same.
Nah na nah na poopooooooo. Adrock out!
Thanks for the grammar check brah!
Last position was 416,000 for Jim1234 so the buy and the sell is 800,000.
But what do I know....nah na nah na poopooooooo...brah.
The company stated to one of our message board member that updates would be made on the website and Aug 13 if deemed to be needed.
So did I.
Jim1234 posted he sold and the message was deleted.
Nah na nah na poopoo
Russo theirs your seller.